Edwards Lifesciences | EW - Market Capitalization


Edwards Lifesciences reported $54.27B in Market Capitalization this October of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 171.01B 12.96B Sep/2026
Artivion USD 2.18B 176M Dec/2025
AtriCure USD 1.42B 28M Jun/2026
Baxter International USD 12.41B 1.4B Sep/2026
Becton, Dickinson and Co. USD 41.7B 3.07B Jun/2026
Boston Scientific USD 63.26B 181M Sep/2026
Cooper Companies USD 14.1B 1.83B Jun/2026
Dexcom USD 32.56B 6.57B Sep/2026
Edwards Lifesciences USD 52.09B 5.92B Jun/2026
Globus Medical USD 10.73B 963M Jun/2026
ICU Medical USD 3.66B 434M Jun/2026
Insulet USD 10.55B 3.99B Jun/2026
Integra LifeSciences USD 1.27B 131M Sep/2026
Intuitive Surgical USD 143.65B 2.81B Sep/2026
J&J USD 653.61B 42.25B Sep/2026
Medtronic USD 109.3B 2.33B Jun/2026
Merit Medical Systems USD 5.15B 1.01B Sep/2026
Stryker USD 105.63B 15.07B Sep/2026
Tandem Diabetes Care USD 1.03B 276M Jun/2026
Teleflex USD 5.61B 317M Jun/2026
Zimmer Biomet Holdings USD 16.66B 845M Jun/2026